Fred Aslan

Fred Aslan is CEO of Artiva Biotherapeutics, which is developing antibody-directed allogeneic NK-cell therapies for autoimmune disease.

Articles by Fred Aslan

Close-up of blood cells highlighting B cells for therapy.
| 6 min read
Articles
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved researcher transferring liquid into a microplate using a multichannel pipette.
A practical guide to better pipetting
Discover practical strategies to improve pipetting accuracy, reproducibility, ergonomics, and instrument performance across diverse laboratory workflows.
Ebooks
Integra
Multichannel pipette dispensing a serial dilution into a 96-well microplate.
Optimizing automated workflows for serial dilutions
Discover practical strategies for performing reliable serial dilutions with optimized liquid handling and mixing.
Application Note
Integra
Serial dilution series in microcentrifuge tubes showing progressively decreasing concentrations of a purple solution.
Mastering pipetting for accurate serial dilutions
Learn best practices for improving the accuracy, precision, and reproducibility of automated serial dilution workflows.
Application Note
Integra